A new rapid antigen test kit can help identify those affected by COVID-19 in 15 minutes. The test is designed by E25Bio, a Massachusetts. US-based startup that has previously conducted clinical trials for dengue and zika. The company, which started at MIT Tata Center, was funded in its early days by the Tata Center for Technology and Design of MIT Energy Initiative, supported by Tata Trusts. The test can detect whether a person has been affected by COVID-19 due to coronavirus, in a much shorter time than other methods, and can play an important role in helping us return to normalcy from the current epidemic situation.
Last month, E25Bio raised $ 2 million (about Rs 15.3 crore) from Khosla Ventures to build a rapid COVID-19 diagnosis kit. According to a report published by MIT, the two-year-old firm quickly began testing on human samples, and in about a month, has finished work on its kit.
“The Tata Center and Tata Trusts believed in us and funded our initial research before anyone else. Together with our manufacturing partner, High Media in India, we are extremely grateful for all their support, ”said Irene Bosch, CTO at ETOBO.
The diagnostic test resembles an over-the-counter pregnancy test, although unfortunately, you still require a nasopharyngeal swab to perform the test. “Our team is also working to determine if an alternative sample, like saliva, can be considered, which will help reduce patient discomfort,” Bosch said.
What’s more, testing is also going to be much cheaper than other options. “Given the exponential rate of virus spread, there is a critical need to deploy rapid, reliable, inexpensive, and easy-to-use point-of-care trials to quickly detect and isolate patients’ needs. To be able to level the curve. Urgent care, ”the team at MIT noted.
Fast and cheap tests are going to be very important in the fight against the spread of coronaviruses. Being able to detect COVID-19 in a timely manner will depend on extensive testing, and rapid testing will be important in opening up businesses such as air travel. At the moment, airline passengers traveling from Dubai-based Emirates reportedly have to undergo a blood test for COVID-19 before flying, and this could be the future of air travel until the vaccine or treatment develops.